Clinical trial
A Randomized Double Blind Trial of Vasoactive Drugs for the Management of Shock in the ICU
NCT02118467 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blind Trial of Vasoactive Drugs for the Management of Shock in the ICU
- Lead sponsor
- University of Chicago
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 15, 2014
- Completion date
- December 1, 2026
- Enrollment
- 836 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.